Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAIRPARKII: Deferiprone in Parkinson's Disease
NCT02655315Phase 2Completed
- Sponsor
- CHU de Lille
- Start
- Feb 2016
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of deferiprone in Parkinson's disease (PD), sponsored by CHU de Lille. Started Feb 2016; status: completed.
02
Drugs
deferiprone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02655315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02655315.